Skip to main content

N of 1 trials and the individualization of drug treatments

The ultimate goal of evidence based medicine is the provision of care for the individual patient using the best evidence. The responsibility falls on the clinician to determine what is best for the individual patient, and also on the patient to use the prescribed drugs appropriately. In an attempt to prove the effectiveness of their medications patients have been known to adjust their drug treatment by increasing or decreasing doses and clinicians have also been known to perform trials of therapy in circumstances where there is insufficient evidence-based information for the treatment of an individual patient. Therefore, there is need for a standardized approach to determining treatment effect in the individual patient. The N-of-1 trial provides a means of determining individualised treatment for a patient. They are single-subject, multiple crossover trials where participants are switched periodically from active to control (standard care, placebo) or between active treatments (2 or more) or between several doses of a treatment.

This project aims to provide a detailed typology of N of 1 designs; assess the particular challenges that N of 1 trials can address, and for which conditions N of 1 trials are most useful; and determine if N of 1 trials is an effective way of determining treatment for a patient.

The first phase of the project involves a systematic review of N-of-1 trials, which will help to answer above questions. Second phase involves a survey or interviews with clinicians involved in N-of-1 trials to determine its clinical application.

For more information, please read the project proposal.

Publications

Demeyin WA, Frost J, Ukoumunne OC, Briscoe S, Britten N (2017). N of 1 trials and the optimal individualisation of drug treatments: a systematic review protocol. Systematic Reviews 6(90)

Upcoming Events

Jul
02

Searching and Review Clinic

South Cloisters 2.35, St Luke's Campus, University of Exeter

These clinics have been set up to help the PenCLAHRC Evidence Synthesis Team to manage and respond...
More information

Jul
02

PPI Advice Clinic

South Cloisters, St Luke's Campus, University of Exeter

Patient and Public Involvement Advice Clinics Held every month 30 minutes between 12pm-1pm Whatever your query, from...
More information

Calendar

News

Professor Tamsin Ford awarded CBE for services to psychiatry

17 June 2019

Tamsin Ford, Professor of Child and Adolescent Psychiatry at the University of Exeter Medical School...
Read more

Leading Plymouth University Dementia champion awarded British Empire Medal

10 June 2019

Ian Sherriff, Academic Partnership Lead for Dementia at the University of Plymouth and founder member...
Read more

How to improve outcomes for children and young people with long term conditions – the evidence is in

05 June 2019

Children and young people suffering with long term physical conditions can find anxiety and depression...
Read more

News

Research Projects

Social Prescribing - Understanding what works in, and supporting provision of, nature - based therapeutic interventions for people with an identifiable mental illness

Theme: Healthy People, Healthy Environments

We have been awarded funding from DEFRA to identify what works in the use of...
Read more

Social Prescribing - Cornwall and Plymouth Researcher in Residence

Theme: Healthy People, Healthy Environments

Evaluation work by a Researcher in Residence to assess implementation, reach, scope and acceptability of...
Read more

Research Projects